$ Value
$607K
Shares
12,344
Price
$49
Filed
Apr 3
Insider
Name
Turtle Cameron
Title
Chief Executive Officer
CIK
0001758363
Roles
Transaction Details
Transaction Date
2026-04-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
630,196
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.64 to $49.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range. | Includes 116,168 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.64 to $50.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Filing Info
Turtle Cameron's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | SYRE | ▼ | $607K |
| 2026-04-01 | SYRE | ▼ | $133K |
| 2026-03-23 | DMRA | A | $0 |
| 2025-11-03 | SYRE | ▼ | $651K |
| 2025-11-03 | SYRE | ▼ | $399K |
| 2025-06-02 | ORKA | A | $0 |
Other Insiders at SYRE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Turtle Cameron
Chief Executive Officer
|
— | $133K | 2026-04-01 |
|
Burrows Scott L
Chief Financial Officer
|
— | $370K | 2026-04-01 |
|
Sloan Sheldon
Chief Medical Officer
|
— | $398K | 2026-04-01 |